{"id":"W3154880036","doi":"10.1016/j.esmoop.2021.100117","title":"Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring","year":2021,"lang":"en","type":"review","venue":"ESMO Open","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":71,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University","funders":"Cilag; Foundation Medicine; Chugai Pharmaceutical; Novartis Farmacéutica; European Society for Medical Oncology; Shire; Eisai; Seagen; G1 Therapeutics; Genentech; Veracyte; SkylineDx; Roche; Nordic Nanovector; Meso Scale Diagnostics; Les Laboratories Pierre Fabre; Celldex Therapeutics; Ipsen; Array BioPharma; Merck KGaA; Taiho Pharmaceutical; F. Hoffmann-La Roche; Amgen; Boehringer Ingelheim; Radius Health; Daiichi Sankyo Europe; Servier; Bayer; Gilead Sciences; NeraCare; Cancer Research UK; World Health Organization; Sanofi; Novartis; Ariad Pharmaceuticals; Pfizer; AstraZeneca; Eli Lilly and Company; Samsung; Bristol-Myers Squibb","keywords":"Medicine; Clinical trial; Scale (ratio); Food and drug administration; Agency (philosophy); Clinical study design; Medical physics; Research design; Risk analysis (engineering); Pathology; Statistics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009654704,0.0004237222,0.005537518,0.0003717436,0.0001210763,0.0002302106,0.001781346,0.0003135554,0.0003118125],"category_scores_gemma":[0.001023781,0.0003754707,0.0004876948,0.0006468468,0.0002974563,0.0007009659,0.0021198,0.0005065448,0.00000817981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005622031,"about_ca_system_score_gemma":0.0003340007,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01299063,"about_ca_topic_score_gemma":0.0235644,"domain_scores_codex":[0.9930859,0.0002359476,0.004787419,0.001424472,0.00009607363,0.0003701458],"domain_scores_gemma":[0.9922962,0.002461151,0.003270358,0.001718962,0.00008338685,0.0001699075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003146427,0.0003112285,0.7277645,0.0002809039,0.001407278,0.000004823977,0.0001451655,0.00002104453,1.005577e-9,0.001099552,0.0002532838,0.2686807],"study_design_scores_gemma":[0.00154913,0.0002734257,0.8054482,0.0008715961,0.001896804,0.000003445972,0.0006417041,0.0001121363,3.28913e-7,0.0003133086,0.1883831,0.0005068765],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.09517311,0.8981757,0.0002577992,0.00008507785,0.0006763173,0.002432444,0.002238571,0.000007954501,0.0009529911],"genre_scores_gemma":[0.05499976,0.9429012,0.00104517,0.00005409203,0.0002022053,0.0001181503,0.0004851521,0.00005143188,0.0001428217],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2681738,"threshold_uncertainty_score":0.9998697,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5438960934358554,"score_gpt":0.5372332370321362,"score_spread":0.00666285640371922,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}